Introduksjon
Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for David Thomas Evans. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.
Gjennomsnittlig handelslønnsomhet
Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,
Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.
Oppdateringsfrekvens: Daglig
Selskaper med rapporterte insiderposisjoner
SEC-arkiveringene indikerer at David Thomas Evans har rapporterte beholdninger av handler i følgende selskaper:
Verdipapir | Navn | Siste rapporterte høydepunkter |
---|---|---|
US:CDLX / Cardlytics, Inc. | Chief Administrative Officer | 0 |
Hvordan tolke diagrammene
De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av David Thomas Evans. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.
Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.
Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.
Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.
Internkjøp CDLX / Cardlytics, Inc. - Analyse av kortsiktig fortjeneste
I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i CDLX / Cardlytics, Inc.. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til maks |
Pris ved maks |
Maks fortjeneste ($) |
Maks fortjeneste (%) |
---|---|---|---|---|---|---|---|---|---|---|---|
2018-02-13 | CDLX | Evans David Thomas | 1 500 | 13,0000 | 1 500 | 13,0000 | 19 500 | 216 | 27.6500 | 21 975 | 112,69 |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Internhandel CDLX / Cardlytics, Inc. - Analyse av kortsiktig tap
I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i CDLX / Cardlytics, Inc.. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Innsidernes handelshistorikk
Tabellen viser den komplette listen over innsidehandler gjort av David Thomas Evans som avslørt til Securies Exchange Comission (SEC).
Fildato | Transaksjonsdato | Skjema | Ticker | Verdipapir | Kode | Aksjer | Gjenværende aksjer | Prosent endring |
Aksje pris |
Transaksjons verdi |
Gjenværende verdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2020-10-06 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
M - Exercise | −10 937 | 0 | −100,00 | ||||
2020-10-06 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Unit |
M - Exercise | −87 500 | 0 | −100,00 | ||||
2020-10-06 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 10 937 | 106 013 | 11,50 | ||||
2020-10-06 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 87 500 | 95 076 | 1 154,96 | ||||
2020-08-28 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −1 432 | 7 576 | −15,90 | 81,70 | −116 994 | 618 959 | |
2020-08-28 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −1 049 | 9 008 | −10,43 | 80,81 | −84 770 | 727 936 | |
2020-08-28 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −2 502 | 10 057 | −19,92 | 80,10 | −200 410 | 805 566 | |
2020-08-28 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
M - Exercise | −10 937 | 10 937 | −50,00 | ||||
2020-08-28 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 10 937 | 12 559 | 674,29 | ||||
2020-08-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −86 | 1 622 | −5,04 | 79,62 | −6 847 | 129 144 | |
2020-08-13 |
|
4 | CDLX |
Cardlytics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −4 769 | 3 125 | −60,41 | ||||
2020-08-13 |
|
4 | CDLX |
Cardlytics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −4 769 | 3 125 | −60,41 | ||||
2020-08-13 |
|
4 | CDLX |
Cardlytics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −5 509 | 0 | −100,00 | ||||
2020-08-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −15 047 | 1 708 | −89,81 | 77,14 | −1 160 726 | 131 755 | |
2020-08-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 4 769 | 16 755 | 39,79 | 20,00 | 95 380 | 335 100 | |
2020-08-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 4 769 | 11 986 | 66,08 | 30,44 | 145 168 | 364 854 | |
2020-08-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 5 509 | 7 217 | 322,54 | 20,00 | 110 180 | 144 340 | |
2020-08-13 |
|
4 | CDLX |
Cardlytics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −700 | 7 894 | −8,15 | ||||
2020-08-13 |
|
4 | CDLX |
Cardlytics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −700 | 7 894 | −8,15 | ||||
2020-08-13 |
|
4 | CDLX |
Cardlytics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −741 | 5 509 | −11,86 | ||||
2020-08-13 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Units |
M - Exercise | −208 | 0 | −100,00 | ||||
2020-08-13 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Units |
A - Award | 208 | 208 | |||||
2020-08-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −401 | 1 708 | −19,01 | 76,05 | −30 496 | 129 893 | |
2020-08-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −13 019 | 2 109 | −86,06 | 75,55 | −983 585 | 159 335 | |
2020-08-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 700 | 15 128 | 4,85 | 20,00 | 14 000 | 302 560 | |
2020-08-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 700 | 14 428 | 5,10 | 30,44 | 21 308 | 439 188 | |
2020-08-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 741 | 13 728 | 5,71 | 20,00 | 14 820 | 274 560 | |
2020-08-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 208 | 12 987 | 1,63 | ||||
2020-05-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −4 512 | 13 479 | −25,08 | 66,98 | −302 214 | 902 823 | |
2020-05-27 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
M - Exercise | −10 938 | 21 874 | −33,34 | ||||
2020-05-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −700 | 12 779 | −5,19 | 67,48 | −47 236 | 862 327 | |
2020-05-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 10 938 | 17 991 | 155,08 | ||||
2020-05-22 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −150 | 7 053 | −2,08 | 67,77 | −10 166 | 477 990 | |
2020-05-22 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Units |
M - Exercise | −355 | 0 | −100,00 | ||||
2020-05-22 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Units |
A - Award | 355 | 355 | |||||
2020-05-22 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 355 | 7 203 | 5,18 | ||||
2020-03-11 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −800 | 6 592 | −10,82 | 45,46 | −36 368 | 299 672 | |
2020-03-11 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −5 046 | 7 392 | −40,57 | 44,48 | −224 446 | 328 796 | |
2020-03-04 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Unit |
A - Award | 87 500 | 87 500 | |||||
2020-03-04 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −4 310 | 12 438 | −25,73 | 78,80 | −339 628 | 980 114 |
2020-03-02 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
M - Exercise | −10 938 | 32 812 | −25,00 | ||||
2020-03-02 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 10 938 | 16 748 | 188,26 | ||||
2020-02-18 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −3 000 | 5 810 | −34,05 | 98,12 | −294 360 | 570 077 |
2020-02-04 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −17 574 | 8 810 | −66,61 | 84,71 | −1 488 694 | 746 295 |
2020-02-04 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −4 426 | 26 384 | −14,37 | 83,89 | −371 297 | 2 213 354 |
2020-01-28 |
|
4 | CDLX |
Cardlytics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | X | −25 781 | 11 719 | −68,75 | |||
2020-01-28 |
|
4 | CDLX |
Cardlytics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | X | −28 906 | 8 594 | −77,08 | |||
2020-01-28 |
|
4 | CDLX |
Cardlytics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | X | −53 757 | 6 250 | −89,58 | |||
2020-01-28 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −5 777 | 30 810 | −15,79 | 87,68 | −506 527 | 2 701 421 |
2020-01-28 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −9 937 | 36 587 | −21,36 | 86,97 | −864 221 | 3 181 971 |
2020-01-28 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −24 635 | 46 524 | −34,62 | 85,80 | −2 113 683 | 3 991 759 |
2020-01-28 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −30 425 | 71 159 | −29,95 | 85,06 | −2 587 950 | 6 052 785 |
2020-01-28 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −29 096 | 101 584 | −22,27 | 83,99 | −2 443 773 | 8 532 040 |
2020-01-28 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | X | 25 781 | 130 680 | 24,58 | 30,44 | 784 774 | 3 977 899 |
2020-01-28 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | X | 28 906 | 104 899 | 38,04 | 20,00 | 578 120 | 2 097 980 |
2020-01-28 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | X | 53 757 | 75 993 | 241,76 | 20,00 | 1 075 140 | 1 519 860 |
2020-01-15 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −3 000 | 22 236 | −11,89 | 85,02 | −255 060 | 1 890 505 |
2020-01-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −600 | 25 236 | −2,32 | 63,38 | −38 028 | 1 599 458 |
2020-01-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −2 665 | 25 836 | −9,35 | 62,29 | −166 003 | 1 609 324 |
2020-01-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −12 115 | 28 501 | −29,83 | 61,60 | −746 284 | 1 755 662 |
2020-01-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −6 620 | 40 616 | −14,01 | 60,36 | −399 583 | 2 451 582 |
2019-12-16 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −3 000 | 47 236 | −5,97 | 57,00 | −171 000 | 2 692 452 |
2019-12-05 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −2 586 | 50 236 | −4,90 | 60,00 | −155 160 | 3 014 160 |
2019-12-05 |
|
4 | CDLX |
Cardlytics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −22 500 | 0 | −100,00 | ||||
2019-12-05 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −2 414 | 52 822 | −4,37 | 60,00 | −144 840 | 3 169 320 |
2019-12-05 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −17 000 | 55 236 | −23,53 | 55,94 | −950 980 | 3 089 902 |
2019-12-05 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 22 500 | 72 236 | 45,24 | 9,08 | 204 300 | 655 903 | |
2019-11-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −6 540 | 49 034 | −11,77 | 56,20 | −367 548 | 2 755 711 | |
2019-11-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −14 741 | 55 574 | −20,96 | 55,88 | −823 727 | 3 105 475 | |
2019-11-27 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
M - Exercise | −21 875 | 43 750 | −33,33 | ||||
2019-11-27 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
M - Exercise | −21 875 | 43 750 | −33,33 | ||||
2019-11-27 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
A - Award | 43 750 | 87 500 | 100,00 | ||||
2019-11-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 21 875 | 70 315 | 45,16 | ||||
2019-11-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 21 875 | 70 315 | 45,16 | ||||
2019-11-15 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −3 000 | 26 565 | −10,15 | 57,12 | −171 360 | 1 517 393 |
2019-11-15 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −2 000 | 29 565 | −6,34 | 47,65 | −95 300 | 1 408 772 |
2019-11-15 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −5 000 | 31 565 | −13,67 | 50,00 | −250 000 | 1 578 250 |
2019-11-15 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −5 000 | 36 565 | −12,03 | 55,00 | −275 000 | 2 011 075 |
2019-11-01 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −5 000 | 41 565 | −10,74 | 41,26 | −206 300 | 1 714 972 |
2019-10-30 |
|
4 | CDLX |
Cardlytics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | X | −3 906 | 0 | −100,00 | |||
2019-10-30 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −6 906 | 46 565 | −12,92 | 40,00 | −276 240 | 1 862 600 |
2019-10-30 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | X | 3 906 | 53 471 | 7,88 | 20,00 | 78 120 | 1 069 420 |
2019-10-15 |
|
4 | CDLX |
Cardlytics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | X | −31 962 | 3 906 | −89,11 | |||
2019-10-15 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −3 000 | 49 565 | −5,71 | 37,15 | −111 450 | 1 841 340 |
2019-10-15 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −21 555 | 52 565 | −29,08 | 37,50 | −808 312 | 1 971 188 |
2019-10-15 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | X | 31 962 | 74 120 | 75,81 | 20,00 | 639 240 | 1 482 400 |
2019-10-15 |
|
4 | CDLX |
Cardlytics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | X | −1 631 | 35 868 | −4,35 | |||
2019-10-15 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 100 | 42 158 | −2,54 | 37,50 | −41 250 | 1 580 925 |
2019-10-15 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | X | 1 631 | 43 258 | 3,92 | 20,00 | 32 620 | 865 160 |
2019-10-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −2 000 | 41 627 | −4,58 | 35,00 | −70 000 | 1 456 945 |
2019-08-28 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
A - Award | 43 750 | 43 750 | |||||
2019-08-22 |
|
4 | CDLX |
Cardlytics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | 10 000 | 22 500 | 80,00 | ||||
2019-08-22 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 10 000 | 43 627 | 29,74 | 9,08 | 90 800 | 396 133 | |
2019-08-19 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 500 | 33 627 | −4,27 | 33,93 | −50 895 | 1 140 964 |
2019-07-15 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 500 | 35 127 | −4,10 | 28,14 | −42 210 | 988 474 |
2019-06-19 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 500 | 36 627 | −3,93 | 25,18 | −37 770 | 922 268 |
2019-05-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 500 | 38 127 | −3,79 | 19,99 | −29 985 | 762 159 |
2019-04-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 500 | 38 664 | −3,73 | 15,42 | −23 125 | 596 071 |
2019-03-29 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −819 | 40 164 | −2,00 | 16,52 | −13 530 | 663 509 |
2019-03-29 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −831 | 40 983 | −1,99 | 16,30 | −13 545 | 668 023 |
2019-03-29 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −855 | 41 814 | −2,00 | 15,84 | −13 543 | 662 334 |
2019-03-26 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −863 | 42 669 | −1,98 | 15,68 | −13 532 | 669 050 |
2019-03-26 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −887 | 43 532 | −2,00 | 15,26 | −13 536 | 664 298 |
2019-03-26 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −866 | 44 419 | −1,91 | 15,65 | −13 553 | 695 157 |
2019-03-21 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −850 | 45 285 | −1,84 | 15,92 | −13 532 | 720 937 |
2019-03-21 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −870 | 46 135 | −1,85 | 15,56 | −13 537 | 717 861 |
2019-03-21 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −864 | 47 005 | −1,80 | 15,68 | −13 548 | 737 038 |
2019-03-18 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −871 | 47 869 | −1,79 | 15,54 | −13 535 | 743 884 |
2019-03-18 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −879 | 48 740 | −1,77 | 15,39 | −13 528 | 750 109 |
2019-03-18 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −884 | 49 619 | −1,75 | 15,32 | −13 543 | 760 163 |
2019-03-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −859 | 50 503 | −1,67 | 15,75 | −13 529 | 795 422 |
2019-03-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −846 | 51 362 | −1,62 | 15,99 | −13 528 | 821 278 |
2019-03-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −849 | 52 208 | −1,60 | 15,95 | −13 542 | 832 718 |
2018-12-12 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −14 047 | 53 057 | −20,93 | 13,33 | −187 247 | 707 250 | |
2018-12-12 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
M - Exercise | −75 000 | 0 | −100,00 | ||||
2018-12-12 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −13 100 | 67 104 | −16,33 | 13,69 | −179 339 | 918 654 | |
2018-12-12 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 75 000 | 80 204 | 1 441,20 | ||||
2018-12-07 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
A - Award | 75 000 | 75 000 | |||||
2018-08-21 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −1 198 | 4 161 | −22,35 | 20,66 | −24 751 | 85 966 | |
2018-02-15 |
|
4 | CDLX |
Cardlytics, Inc.
Series G' Redeemable Convertible Preferred Stock |
C - Conversion | −3 859 | 0 | −100,00 | ||||
2018-02-15 |
|
4 | CDLX |
Cardlytics, Inc.
Series G' Redeemable Convertible Preferred Stock |
M - Exercise | 1 193 | 3 859 | 44,75 | ||||
2018-02-15 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Unit |
M - Exercise | −1 193 | 0 | −100,00 | ||||
2018-02-15 |
|
4 | CDLX |
Cardlytics, Inc.
Series G' Redeemable Convertible Preferred Stock |
M - Exercise | 2 045 | 2 666 | 329,31 | ||||
2018-02-15 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Unit |
M - Exercise | −2 045 | 0 | −100,00 | ||||
2018-02-15 |
|
4 | CDLX |
Cardlytics, Inc.
Series G' Redeemable Convertible Preferred Stock |
M - Exercise | 621 | 621 | |||||
2018-02-15 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Unit |
M - Exercise | −621 | 0 | −100,00 | ||||
2018-02-15 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
P - Purchase | 1 500 | 5 359 | 38,87 | 13,00 | 19 500 | 69 667 | |
2018-02-15 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
C - Conversion | 3 859 | 3 859 |